Lomond Therapeutics Holdings, Inc. SEC EDGAR Filings (CIK 0001900520)

SEC EDGAR filings, ownership reports, and insider transactions for Lomond Therapeutics Holdings, Inc..

Industry
Pharmaceutical Preparations (Office Of Life Sciences)
Business address
C/O Lomond Therapeutics Holdings, Inc., 8 The Green Ste 8490, Dover, DE, 19901
State of incorporation
DE
Fiscal year end
31 December
Former names
Venetian-1 Acquisition Corp. (to 28 Oct 2024)
⭐ Add to watchlist ⭐
Get insider transactions for this issuer
Lomond Therapeutics Holdings, Inc. has filed 67 SEC EDGAR filings since 21 Dec 2021

Latest Filings

Recent SEC filings for Lomond Therapeutics Holdings, Inc. including 8-K, 10-Q, SCHEDULE 13G/A and more.

Form type Document Filing Description Filing date Reporting date File number(s)
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K CURRENT REPORT 13 Jan 2026 08 Jan 2026 000-56377
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K CURRENT REPORT 13 Jan 2026 07 Jan 2026 000-56377
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q QUARTERLY REPORT 14 Nov 2025 30 Sep 2025 000-56377
SCHEDULE 13G/A Open SCHEDULE 13G/A document View SEC filing for SCHEDULE 13G/A 13 Nov 2025 005-93945
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q QUARTERLY REPORT 14 Aug 2025 30 Jun 2025 000-56377
S-1/A Open S-1/A document | Open XBRL data View SEC filing for S-1/A AMENDMENT NO. 4 TO FORM S-1 01 Aug 2025 333-283508
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K CURRENT REPORT 20 Jun 2025 20 Jun 2025 000-56377
S-1/A Open S-1/A document | Open XBRL data View SEC filing for S-1/A AMENDMENT NO. 3 TO FORM S-1 18 Jun 2025 333-283508
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q QUARTERLY REPORT 20 May 2025 31 Mar 2025 000-56377
NT 10-Q Open NT 10-Q document View SEC filing for NT 10-Q NOTIFICATION OF LATE FILING 15 May 2025 31 Mar 2025 000-56377
10-K Open 10-K document | Open XBRL data View SEC filing for 10-K ANNUAL REPORT 15 Apr 2025 31 Dec 2024 000-56377
NT 10-K Open NT 10-K document View SEC filing for NT 10-K NOTIFICATION OF LATE FILING 01 Apr 2025 31 Dec 2024 000-56377
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K CURRENT REPORT 28 Mar 2025 24 Mar 2025 000-56377
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 26 Mar 2025 005-93945
S-1/A Open S-1/A document | Open XBRL data View SEC filing for S-1/A AMENDMENT NO. 2 TO FORM S-1 10 Mar 2025 333-283508
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K CURRENT REPORT 20 Feb 2025 13 Feb 2025 000-56377
SCHEDULE 13G/A Open SCHEDULE 13G/A document View SEC filing for SCHEDULE 13G/A 14 Feb 2025 005-93945
SCHEDULE 13G/A Open SCHEDULE 13G/A document View SEC filing for SCHEDULE 13G/A 14 Feb 2025 005-93945
D/A Open D/A document View SEC filing for D/A 11 Feb 2025 021-529644
S-1/A Open S-1/A document | Open XBRL data View SEC filing for S-1/A AMENDMENT NO. 1 TO FORM S-1 31 Jan 2025 333-283508
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 31 Jan 2025 005-93945
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K CURRENT REPORT 30 Jan 2025 24 Jan 2025 000-56377
S-8 Open S-8 document View SEC filing for S-8 REGISTRATION STATEMENT 21 Jan 2025 333-284390
S-1 Open S-1 document | Open XBRL data View SEC filing for S-1 REGISTRATION STATEMENT 27 Nov 2024 333-283508
8-K/A Open 8-K/A document | Open XBRL data View SEC filing for 8-K/A AMENDMENT NO. 1 TO FORM 8-K 22 Nov 2024 01 Nov 2024 000-56377
D Open D document View SEC filing for D 18 Nov 2024 021-529644
SC 13D Open SC 13D document View SEC filing for SC 13D SCHEDULE 13D 08 Nov 2024 005-93945
SC 13D Open SC 13D document View SEC filing for SC 13D SCHEDULE 13D 08 Nov 2024 005-93945
SC 13D Open SC 13D document View SEC filing for SC 13D SCHEDULE 13D 08 Nov 2024 005-93945
SC 13G Open SC 13G document View SEC filing for SC 13G SC 13G 08 Nov 2024 005-93945
SC 13G Open SC 13G document View SEC filing for SC 13G SC 13G 08 Nov 2024 005-93945
SC 13G Open SC 13G document View SEC filing for SC 13G SC 13G 08 Nov 2024 005-93945
SC 13G Open SC 13G document View SEC filing for SC 13G 08 Nov 2024 005-93945
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K CURRENT REPORT 07 Nov 2024 01 Nov 2024 000-56377
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 05 Nov 2024 01 Nov 2024
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 05 Nov 2024 01 Nov 2024
4 Open 4 document View SEC filing for 4 05 Nov 2024 01 Nov 2024
4 Open 4 document View SEC filing for 4 05 Nov 2024 01 Nov 2024
4 Open 4 document View SEC filing for 4 05 Nov 2024 01 Nov 2024
4 Open 4 document View SEC filing for 4 05 Nov 2024 01 Nov 2024
3 Open 3 document View SEC filing for 3 05 Nov 2024 01 Nov 2024
3 Open 3 document View SEC filing for 3 05 Nov 2024 01 Nov 2024
3 Open 3 document View SEC filing for 3 05 Nov 2024 01 Nov 2024
3 Open 3 document View SEC filing for 3 05 Nov 2024 01 Nov 2024
3 Open 3 document View SEC filing for 3 05 Nov 2024 01 Nov 2024
3 Open 3 document View SEC filing for 3 05 Nov 2024 01 Nov 2024
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q QUARTERLY REPORT 28 Oct 2024 30 Sep 2024 000-56377
SC 14F1 Open SC 14F1 document View SEC filing for SC 14F1 SCHEDULE 14F-1 02 Oct 2024 005-93945
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q QUARTERLY REPORT 13 Aug 2024 30 Jun 2024 000-56377
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q QUARTERLY REPORT 14 May 2024 31 Mar 2024 000-56377
10-K Open 10-K document | Open XBRL data View SEC filing for 10-K ANNUAL REPORT 01 Apr 2024 31 Dec 2023 000-56377
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q QUARTERLY REPORT 13 Nov 2023 30 Sep 2023 000-56377
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q QUARTERLY REPORT 10 Aug 2023 30 Jun 2023 000-56377
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q QUARTERLY REPORT 15 May 2023 31 Mar 2023 000-56377
10-K Open 10-K document | Open XBRL data View SEC filing for 10-K ANNUAL REPORT 31 Mar 2023 31 Dec 2022 000-56377
SC 13G Open SC 13G document View SEC filing for SC 13G SCHEDULE 13G 13 Feb 2023 005-93945
SC 13G Open SC 13G document View SEC filing for SC 13G SCHEDULE 13G 10 Feb 2023 005-93945
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q QUARTERLY REPORT 14 Nov 2022 30 Sep 2022 000-56377
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q QUARTERLY REPORT 15 Aug 2022 30 Jun 2022 000-56377
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K CURRENT REPORT 28 Jul 2022 22 Jul 2022 000-56377
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K CURRENT REPORT 19 Jul 2022 13 Jul 2022 000-56377
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q QUARTERLY REPORT 16 May 2022 31 Mar 2022 000-56377
10-K Open 10-K document View SEC filing for 10-K ANNUAL REPORT 31 Mar 2022 31 Dec 2021 000-56377
SEC STAFF ACTION Open SEC STAFF ACTION document View SEC filing for SEC STAFF ACTION 10 Feb 2022
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 10 Feb 2022 10 Feb 2022
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 10 Feb 2022 10 Feb 2022
10-12G Open 10-12G document View SEC filing for 10-12G GENERAL FORM FOR REGISTRATION OF SECURITIES 21 Dec 2021 000-56377

About this filer

Lomond Therapeutics Holdings, Inc. files with the SEC under CIK 0001900520. This page aggregates EDGAR filings and related ownership activity.

Industry: Pharmaceutical Preparations.

See insider transactions for this issuer.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages